日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Sequential deregulation of histone marks, chromatin accessibility and gene expression in response to PROTAC-induced degradation of ASH2L

PROTAC诱导的ASH2L降解导致组蛋白修饰、染色质可及性和基因表达的顺序性失调。

Mirna Barsoum # ,Roksaneh Sayadi-Boroujeni # ,Alexander T Stenzel ,Philip Bussmann ,Juliane Lüscher-Firzlaff ,Bernhard Lüscher

Induction of senescence upon loss of the Ash2l core subunit of H3K4 methyltransferase complexes

H3K4甲基转移酶复合物Ash2l核心亚基缺失诱导衰老

Agnieszka Bochyńska ,Alexander T Stenzel ,Roksaneh Sayadi Boroujeni ,Chao-Chung Kuo ,Mirna Barsoum ,Weili Liang ,Philip Bussmann ,Ivan G Costa ,Juliane Lüscher-Firzlaff ,Bernhard Lüscher

Loss of the Ash2l subunit of histone H3K4 methyltransferase complexes reduces chromatin accessibility at promoters

组蛋白 H3K4 甲基转移酶复合物 Ash2l 亚基的丢失降低了启动子处染色质的可及性

Mirna Barsoum #, Alexander T Stenzel #, Agnieszka Bochyńska #, Chao-Chung Kuo #, Alexander Tsompanidis, Roksaneh Sayadi-Boroujeni, Philip Bussmann, Juliane Lüscher-Firzlaff, Ivan G Costa, Bernhard Lüscher

An evaluation of the impact of aloe vera and licorice extracts on the course of experimental pigeon paramyxovirus type 1 infection in pigeons

芦荟和甘草提取物对鸽子实验性副粘液病毒 1 型感染过程的影响评估

D Dziewulska, T Stenzel, M Smialek, B Tykalowski, A Koncicki

A novel FMR1 PCR method for the routine detection of low abundance expanded alleles and full mutations in fragile X syndrome

一种新型 FMR1 PCR 方法,用于常规检测脆性 X 综合征中的低丰度扩增等位基因和完全突变

Stela Filipovic-Sadic, Sachin Sah, Liangjing Chen, Julie Krosting, Edward Sekinger, Wenting Zhang, Paul J Hagerman, Timothy T Stenzel, Andrew G Hadd, Gary J Latham, Flora Tassone

An information-rich CGG repeat primed PCR that detects the full range of fragile X expanded alleles and minimizes the need for southern blot analysis

信息丰富的 CGG 重复引物 PCR 可检测所有脆性 X 扩增等位基因,并最大程度地减少对南方印迹分析的需求

Liangjing Chen, Andrew Hadd, Sachin Sah, Stela Filipovic-Sadic, Julie Krosting, Edward Sekinger, Ruiqin Pan, Paul J Hagerman, Timothy T Stenzel, Flora Tassone, Gary J Latham

Establishment of stably EBV-transformed cell lines from residual clinical blood samples for use in performance evaluation and quality assurance in molecular genetic testing

从残留临床血液样本中建立稳定的 EBV 转化细胞系,用于分子遗传学检测的性能评估和质量保证

Susan H Bernacki, Ana K Stankovic, Laurina O Williams, Jeanne C Beck, James E Herndon, Karen Snow-Bailey, Thomas W Prior, Karla J Matteson, Linda M Wasserman, Eugene C Cole, Timothy T Stenzel